Back
Controladora Vuela Compania de Aviacion SAB de CV 10K Form
Buy
68
VLRS
Controladora Vuela Compania de Aviacion SAB de CV
Last Price:
$7.95
Seasonality Move:
0.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VLRS News And Ratings
See the #1 stock for the next 7 days that we like better than VLRS
VLRS Financial Statistics
Sales & Book Value
Annual Sales: | $3.3B |
---|---|
Cash Flow: | $233M |
Price / Cash Flow: | 0.93 |
Annual Sales: | $2.78 |
Price / Book: | 2.86 |
Profitability
EPS (TTM): | 1.66000 |
---|---|
Net Income (TTM): | $191.8M |
Gross Margin: | $505.2M |
Return on Equity: | 76.33% |
Return on Assets: | 3.63% |
Controladora Vuela Compania de Aviacion SAB de CV Earnings Forecast
Key Controladora Vuela Compania de Aviacion SAB de CV Financial Ratios
-
The Gross Profit Margin over the past 14 years for VLRS is 15.50%.
-
The Selling, General & Administrative Expenses for VLRS have been equal to 9.61% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 2,778.67% of Operating Income.
-
The Net Earning history of VLRS is 0.24% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 8 years.
Controladora Vuela Compania de Aviacion SAB de CV Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Passenger Airlines |
Sector: | Industrials |
Current Symbol: | VLRS |
CUSIP: | 21240E |
Website: | volaris.com |
Debt
Debt-to-Equity Ratio: | 2.31 |
---|---|
Current Ratio: | 0.73 |
Quick Ratio: | 0.56 |
Price-to-Earnings
Trailing P/E Ratio: | 113.57 |
---|---|
Forward P/E Ratio: | 7.56 |
VLRS Technical Analysis vs Fundamental Analysis
Buy
68
Controladora Vuela Compania de Aviacion SAB de CV (VLRS)
is a Buy
Is Controladora Vuela Compania de Aviacion SAB de CV a Buy or a Sell?
-
Controladora Vuela Compania de Aviacion SAB de CV stock is rated a BuyThe current Controladora Vuela Compania de Aviacion SAB de CV [VLRS] share price is $7.95. The Score for VLRS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.